Marketwire (Wed, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
515 people get ETRM articles and Market Currents by email alert.
Get email alerts on ETRM »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Marketwire (Fri, 7:00AM)
-
Marketwire (May 1, 2013)
-
Marketwire (Apr 22, 2013)
-
Marketwire (Mar 12, 2013)
-
-
Marketwire (Feb 27, 2013)
-
Marketwire (Feb 26, 2013)
-
Marketwire (Feb 22, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 20, 2013)
-
Marketwire (Feb 13, 2013)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Insiders Love These 10 Outperforming Healthcare StocksKapitall • Tue, Jul 10, 2012
-
3 Outperforming Stocks Under $5 Being Snapped Up By InsidersKapitall • Thu, Jun 14, 2012
-
-
-
-
3 Rallying Stocks Under $5 Being Bought Up By Hedge FundsKapitall • Tue, May 15, 2012
-
-
3 Rallying Small Caps Selling For Under $5 Being Bought Up By InsidersKapitall • Tue, May 1, 2012
-
-
20 Micro-Cap Stocks Being Snapped Up By Hedge FundsKapitall • Thu, Dec 15, 2011
-
-
-
Marketwire (Wed, 8:00AM)
-
Marketwire (Fri, 7:00AM)
-
Marketwire (May 1, 2013)
-
Marketwire (Apr 22, 2013)
-
Marketwire (Mar 12, 2013)
-
Marketwire (Feb 27, 2013)
-
Marketwire (Feb 26, 2013)
-
Marketwire (Feb 22, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 20, 2013)
-
Marketwire (Feb 13, 2013)
-
at MarketWatch.com (Feb 8, 2013)
-
Marketwire (Nov 19, 2012)
-
Marketwire (Nov 15, 2012)
-
Marketwire (Nov 6, 2012)
-
Marketwire (Oct 24, 2012)
-
Marketwire (Oct 17, 2012)
ETRM vs. ETF Alternatives
Company Description
We are a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity, its associated co-morbidities, and other gastrointestinal disorders. Our proprietary neuroblocking technology, which we refer to as VBLOC... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, May 17, 8:05 AM EnteroMedics (ETRM) rises 15% before the bell after saying it has concluded a pre-Premarket Approval (so you're saying its preliminary?) application meeting at which the FDA said that once the company's application for the Maestro Rechargeable System's VBLOC vagal blocking therapy is accepted, and once a detailed review of the data is validated, the company can "anticipate presenting the PMA before a future FDA Advisory panel." Parsing that language: ETRM plans to submit a PMA in Q2. (PR) Comment! [Healthcare, On the Move]
- Wednesday, May 1, 7:55 AM EnteroMedics (ETRM): Q1 EPS of -$0.14 misses by $0.01. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
Friday, February 22, 12:53 PM
Midday top 10 gainers: WBMD +25%. EDAP +24%. PSDV +24%. ARUN +22%. BLOX +17%. SSTK +16%. FIRE +15%. B +15%. AVG +12%. RKUS +12%.
Midday top 10 losers: ETRM -20%. MMSI -19%. WIFI -18%. FRO -14%. NVGN -12%. CBMX -12%. VOLC -11%. GMXR -16%. RCKY -11%. REED -11%. Comment! [On the Move] - Friday, February 22, 9:26 AM Weight-loss device maker EnteroMedics (ETRM) -19.5% premarket on plans for a $13M public offering of 13.77M common shares and warrants to purchase 5.5M shares. ETRM had ~41.7M shares outstanding as of Dec. 31. Comment! [Healthcare, Consumer, On the Move]
-
Friday, February 22, 9:10 AM
Premarket gainers: WBMD +19%. ARUN +14%. FIRE +13%. JOEZ +11%. CYBX +8%. MRVL +5%. GLUU +5%. HPQ +5%.
Losers: ETRM -17%. RAX -6%. FRO -6%. Comment! [On the Move] - Wednesday, February 13, 6:28 PM EnteroMedics (ETRM): Q4 EPS of -$0.17 misses by $0.03. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
Friday, February 8, 1:00 PM
Midday top 10 gainers: BDCO +32%. CZR +25%. ONCY +23%. LNKD +20%. SNCR +19%. GALT +13%. ZN +13%. FLT +12%. ZNGA +12%. ATVI +11%.
Midday top 10 losers: ETRM -55%. MSON -22%. GUID -21%. NUAN -19%. RVBD -18%. QKLS -16%. JE -14%. NSP -13%. STS -11%. SPWR -10%. Comment! [On the Move] - Thursday, February 7, 6:55 PM EnteroMedics (ETRM) tanks in after hours trading after its electric shock device for weight-loss failed to meet its key goal in clinical trials. The goal was to help patients lose 10% more of their excess weight than patients implanted with a nonworking, or "sham," device. The 10% threshold was agreed upon by the company to meet the FDA's request that the device show " super superiority." However, the company says it still plans to forge ahead with seeking regulatory approval. Shares -50% AH. 3 Comments [Healthcare, On the Move]
- Friday, September 23, 2011, 10:31 AM EnteroMedics (ETRM -9.1%) is down after closing out its secondary offering of 8.8M common shares and 1.76M warrants. It will use the proceeds from the sale to help fund the development of its Maestro RC System, which is used in the treatment of obesity, diabetes and hypertension. Comment! [Healthcare, On the Move]
-
- View all 0 replies
-
Scott Matusow
Live now @ http://bit.ly/wJZkqa Stock pick discussion, my new pick, come join in! $ETRM - View all 8 replies
-
Scott Matusow: no, company said mid q1 = mid feb. not an exact date, My estimation was 2nd week in feb, very close.
-
EnderisLegend: Scott, I ride with you no matter what. like you said, more wins then losses, upset with myself, as I decided to sell thurs, but was too busy
-
- View all 1 replies
-
-
- View all 0 replies
-
sdhir
ETRM link to insider buys - http://bit.ly/oe3XXK Look like substantial buys, was it private placement? - View all 0 replies
-
- View all 0 replies
-
TheMarketFinancial
Patience pays off for $BPAX, don't rush on random rants, see $YMI, and $ETRM...did offerings to public not investors (big diff) and both up - View all 0 replies
-
Top Textrader
Those who still hold ETRM from last week. Payday! News on weight loss studies sending stock flying. Original rec. .71. Set to open at 1.35! - View all 0 replies
-
Top Textrader
Sorry for being off desk this am. Sold remaining ETRM at .80. Still holding long SLTC at .25, CGNH at .145, CXM .65 and TXT at 21.11. - View all 0 replies
-
Top Textrader
Follow up -- Holding half ETRM at .86 - rec'd long at .71. Long CGNH at .145.. Long CXM at .65... Long SLTC at .25. Long TXT at 21.11. - View all 0 replies
LATEST REPLIES
-
Scott Matusow
Live now @ http://bit.ly/wJZkqa Stock pick discussion, my new pick, come join in! $ETRM - View all 8 replies
-
Scott Matusow: no, company said mid q1 = mid feb. not an exact date, My estimation was 2nd week in feb, very close.
-
EnderisLegend: Scott, I ride with you no matter what. like you said, more wins then losses, upset with myself, as I decided to sell thurs, but was too busy
-
- View all 1 replies
-